Holding(s) in Company

Summary by AI BETAClose X

UBS AG, through UBS Group AG, has acquired a significant stake in Renalytix PLC, now holding 7.146810% of the voting rights, which equates to 31,232,896 shares. This acquisition crossed a notification threshold on August 28, 2026, and was reported to the issuer on August 31, 2026. There were no financial instruments with similar economic effects or other voting rights mechanisms involved in this notification.

Disclaimer*

UK 100

Latest directors dealings